日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study

在 t(11;14) 阳性复发/难治性多发性骨髓瘤中,维奈托克-地塞米松与泊马度胺-地塞米松的疗效比较:随机 III 期 CANOVA 研究的主要结果

Popat, Rakesh; Beksac, Meral; Dimopoulos, Meletios A; Gatt, Moshe E; Gay, Francesca; Jo, Jae-Cheol; Kapoor, Prashant; Katodritou, Eirini; Kortüm, K Martin; Ling, Silvia; Nagarajan, Chandramouli; Suzuki, Kenshi; Qiu, Lugui; Onishi, Maika; Ku, Grace; Dail, Monique; Mukherjee, Nabanita; Ross, Jeremy A; Badawi, Mohamed Ali; Fusco, Mary Jean; Dobkowska, Edyta; Arriola, Emma; Bueno, Orlando F; Bahlis, Nizar J; Iida, Shinsuke; Moreau, Philippe; Valent, Jason; Mateos, María-Victoria

Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone

循环肿瘤细胞可预测接受达雷妥尤单抗、硼替佐米、来那度胺和地塞米松治疗的多发性骨髓瘤患者的预后

Bertamini, Luca; Fokkema, Cathelijne; Rodriguez-Otero, Paula; van Duin, Mark; Terpos, Evangelos; D'Agostino, Mattia; van der Velden, Vincent H J; van de Donk, Niels W C J; Delforge, Michel; Driessen, Christoph; Hajek, Roman; Einsele, Hermann; Vangsted, Annette; Vieyra, Diego; Attar, Ricardo; Sitthi-Amorn, Anna; Carson, Robin; Schjesvold, Fredrik; Robak, Pawel; Beksac, Meral; Spencer, Andrew; Broijl, Annemiek; Cupedo, Tom; Moreau, Philippe; Boccadoro, Mario; Sonneveld, Pieter

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study

达雷妥尤单抗四联疗法治疗髓外多发性骨髓瘤患者:来自 II 期前瞻性 EMN19 研究的结果

Beksac, Meral; Fıratlı Tuglular, Tulin; Gay, Francesca; Mina, Roberto; Katodritou, Eirini; Unal, Ali; Cavo, Michele; Ozsan, Guner Hayri; van der Velden, Vincent H J; Beverloo, Berna H; Vermeulen, Michael; van Duin, Mark; Seval, Guldane Cengiz; Sevindik, Omur Gokmen; Merante, Serena; Manousou, Kyriaki; Sonneveld, Peter; Zamagni, Elena; Terpos, Evangelos

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma

Linvoseltamab 与真实世界中国际骨髓瘤工作组标准治疗方案在三线抗肿瘤治疗后复发/难治性多发性骨髓瘤中的比较

Kumar, Shaji; Jagannath, Sundar; Weisel, Katja C; Rosiñol, Laura; Leleu, Xavier; Dimopoulos, Meletios-Athanasios; Kastritis, Efstathios; Siegel, David S; Monge, Jorge; Du, Juan; de la Rubia, Javier; Asensi Cantó, Pedro; Lee, Jae Hoon; Mateos, María-Victoria; Puertas, Borja; Gozzetti, Alessandro; Dytfeld, Dominik; Ocio, Enrique M; Blade, Joan; Ozaki, Shuji; Beksac, Meral; Escalante, Fernando; Nagaraj, Madhu; Hassan, Rafla; Bonar, Nicolle; Spin, Paul; Shokoohi, Mostafa; Siddiqui, Muhaimen; Wang, Di; Hou, Kevin; West, Michael E D; Hampp, Christian; Green, Jeannette; Humblet, Olivier; Breskin, Alexander; Harnett, James; Ge, Wenzhen; Sobel, Rachel E; Jalbert, Jessica J; Kroog, Glenn S; Rodriguez Lorenc, Karen; Ma, Qiufei; Durie, Brian G M

Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy

多发性骨髓瘤合并急性肾衰竭至管型肾病患者的肾功能恢复和生存相关参数

Ludwig, Heinz; Dimopoulos, Meletios Athanasios; Terpos, Evangelos; Bernhard, Sarah; Theodorakakou, Foteini; Beksac, Meral; Cengiz-Seval, Guldane; Leung, Nelson; Arcaini, Luca; Mangiacavalli, Silvia; Bridoux, Frank; Agis, Hermine; Chaidos, Aristeidis; Gay, Francesca; Roccatello, Dario; Hilbe, Wolfgang; Havasi, Andrea; Derudas, Daniele; Klomjit, Nattawat; Jhaveri, Kenar D; De La Rubia Comos, Javier; Kastritis, Efstathios

Is gastroesophageal reflux linked to inflammation-related gestational complications and poor obstetric history?

胃食管反流与炎症相关的妊娠并发症和不良产科病史有关吗?

Beksac, Kemal; Donmez, Hanife Guler; Cagan, Murat; Fadiloglu, Erdem; Beksac, Mehmet Sinan

2025 Update of Cellular Immunotherapy for Plasma Cell Disorders

2025年浆细胞疾病细胞免疫疗法进展

Vural, Ece; Beksac, Meral

Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

作者更正:达雷妥尤单抗联合硼替佐米、来那度胺和地塞米松治疗不适合移植或因故推迟移植的新诊断多发性骨髓瘤:随机3期CEPHEUS试验

Usmani, Saad Z; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J; Venner, Christopher P; Braunstein, Marc; Pour, Ludek; Martí, Josep M; Basu, Supratik; Cohen, Yael C; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Ahmadi, Tahamtan; Liu, Weiping; Wang, Jianping; Chastain, Katherine; Vermeulen, Jessica; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Rowe, Melissa; Carson, Robin; Zweegman, Sonja

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

达雷妥尤单抗联合硼替佐米、来那度胺和地塞米松治疗不适合移植或因故推迟移植的新诊断多发性骨髓瘤:一项随机3期CEPHEUS试验

Usmani, Saad Z; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J; Venner, Christopher P; Braunstein, Marc; Pour, Ludek; Martí, Josep M; Basu, Supratik; Cohen, Yael C; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Ahmadi, Tahamtan; Liu, Weiping; Wang, Jianping; Chastain, Katherine; Vermeulen, Jessica; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Rowe, Melissa; Carson, Robin; Zweegman, Sonja

A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

一项针对复发/难治性多发性骨髓瘤患者的莫达卡福斯普α单药治疗的II期随机研究

Holstein, Sarah A; Atrash, Shebli; Mian, Hira; Dimopoulos, Meletios A; Schjesvold, Fredrik; Popat, Rakesh; Shah, Nishi; Gatt, Moshe E; Gocke, Christian B; Frenzel, Laurent; Touzeau, Cyrille; Beksac, Meral; Manier, Salomon; Magen, Hila; Travis, Patrick; Nadeem, Omar; Suryanarayan, Kaveri; Li, Cheryl; Li, Shuli; Nelson, Allison; Cherepanov, Dasha; Parot, Xavier; Vogl, Dan T